SCHEMBL19579751

SCHEMBL19579751

CCOc1cc(C(=O)O)nc2cc(OC)ccc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.55
PDE3B Q13370 5/20 0.48
PDE3A Q14432 2/20 0.48
KDM4E B2RXH2 7/20 0.45
ALDH1A1 P00352 6/20 0.45
SMN1; SMN2 Q16637 4/20 0.45
HSD17B10 Q99714 3/20 0.43
HPGD P15428 3/20 0.43
TSHR P16473 2/20 0.43
CYP1A2 P05177 1/20 0.43
CTSG P08311 1/20 0.43
KLK7 P49862 1/20 0.43
KLK14 Q9P0G3 1/20 0.43
KLK5 Q9Y337 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
LMNA P02545 2/20 0.43
POLB P06746 1/20 0.43
MTNR1A P48039 2/20 0.43
MTNR1B P49286 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9384011 0.88 ALOX15 (0.53) ALOX15PDE3BPDE3AKDM4EALDH1A1
SCHEMBL8355140 0.88 PDE3B (0.50) PDE3BPDE3AKDM4EALDH1A1HPGD
SCHEMBL30744772 0.83 ALOX15 (0.49) ALOX15KDM4ETSHR
SCHEMBL19579748 0.83 ALOX15 (0.49) ALOX15SMN1; SMN2TSHRMEN1KMT2A
SCHEMBL18528819 0.82 ALOX15 (0.70) ALOX15KDM4EALDH1A1SMN1; SMN2HSD17B10
SCHEMBL31389285 0.82 ALOX15 (0.70) ALOX15KDM4EALDH1A1SMN1; SMN2HSD17B10
SCHEMBL13234529 0.81 KCNH2 (0.51) KDM4EALDH1A1SMN1; SMN2HSD17B10HPGD
SCHEMBL2908122 0.79 ALOX15 (0.50) ALOX15PDE3BPDE3AKDM4EALDH1A1
SCHEMBL16832123 0.79 KDM4E (0.58) ALOX15KDM4EALDH1A1SMN1; SMN2HSD17B10
SCHEMBL9379551 0.79 KCNH2 (0.55) ALOX15KDM4EALDH1A1SMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10849881-B2 Octahydro-cyclobuta[1,2-c;3,4-c′]dipyrrol-2-yl HOFFMANN-LA ROCHE INC. (US) 2020-12-01 US disclosed
US-20180280352-A1 OCTAHYDRO-CYCLOBUTA[1,2-c;3,4-c']DIPYRROL-2-YL HOFFMANN-LA ROCHE INC. (US) 2018-10-04 US disclosed
EP-3074400-B1 OCTAHYDRO-CYCLOBUTA [1,2-C;3,4-C']DIPYRROLE DERIVATIVES AS AUTOTAXIN INHIBITORS HOFFMANN LA ROCHE (CH) 2017-11-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180280352-A1 OCTAHYDRO-CYCLOBUTA[1,2-c;3,4-c']DIPYRROL-2-YL NPY1R, NPY2R, DECR1 ALOX15 1905/4885PDE3B 583/4885PDE3A 526/4885
US-10849881-B2 Octahydro-cyclobuta[1,2-c;3,4-c′]dipyrrol-2-yl NPY1R, NPY2R, DECR1 ALOX15 1933/4885PDE3B 616/4885PDE3A 558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.